Literature DB >> 21282578

Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy.

Amélie Lecleire-Collet1, Isabelle Audo, Mounir Aout, Jean-François Girmens, Rénata Sofroni, Ali Erginay, Jean-François Le Gargasson, Saddek Mohand-Saïd, Taly Meas, Pierre-Jean Guillausseau, Eric Vicaut, Michel Paques, Pascale Massin.   

Abstract

PURPOSE: To correlate retinal function with vascular response to flicker light in normotensive patients with diabetes without diabetic retinopathy (DR).
METHODS: Twenty-eight normotensive patients with diabetes (11 with type 1, 17 with type 2) without DR and 28 sex- and age-matched healthy control subjects underwent color vision and contrast sensitivity testing, pattern, full-field, and multifocal electroretinography, and evaluation of the vascular response to flicker light with the dynamic vessel analyzer.
RESULTS: In the patients with diabetes, electroretinogram (ERG) pattern responses, b-wave in the scotopic bright flash ERG, a-wave and b-wave in the photopic single-flash ERG, and oscillatory potential responses were significantly impaired compared with those in control subjects. Vascular response to flicker light was also impaired in patients with diabetes compared with controls. In the whole population, correlations were found between flicker light-induced arterial retinal vasodilation and the amplitude and implicit time of the N95 wave of pattern ERG (r = -0.27, P = 0.047 and r = -0.35, P = 0.008, respectively), the b-wave implicit time of rod ERG (r = -0.36; P = 0.01) and the oscillatory potentials (r = 0.4; P = 0.003), suggesting that impairment of the vascular response to flicker light may reflect inner retinal neural impairment. However, no correlation between these factors was found when only patients with diabetes were considered.
CONCLUSIONS: In patients with diabetes, neural and neurovascular dysfunctions both precede the onset of clinically detectable DR. To which extent these abnormalities are related to each other remains to be determined. (ClinicalTrials.gov number, NCT00839150.)

Entities:  

Mesh:

Year:  2011        PMID: 21282578     DOI: 10.1167/iovs.10-5960

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

Review 2.  The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes.

Authors:  Carol Yimlui Cheung; M Kamran Ikram; Ronald Klein; Tien Yin Wong
Journal:  Diabetologia       Date:  2015-02-11       Impact factor: 10.122

Review 3.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

4.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

Review 5.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

6.  Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm.

Authors:  John J Wroblewski; Christa McChancy; Kassandra Pickel; Hunter Buterbaugh; Tyler Wieland; Alberto Gonzalez
Journal:  J Diabetes Sci Technol       Date:  2019-10-22

7.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

8.  Early visual deficits in streptozotocin-induced diabetic long evans rats.

Authors:  Moe H Aung; Moon K Kim; Darin E Olson; Peter M Thule; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

9.  Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy.

Authors:  Thomas Forst; Matthias M Weber; Michael Mitry; Lena Müller; Senait Forst; Mukkadar Tanis; Andreas Pfützner; Georg Michelson
Journal:  J Diabetes Sci Technol       Date:  2014-02-21

Review 10.  Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes.

Authors:  Timothy S Kern
Journal:  Diabetes Metab J       Date:  2014-06       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.